Articles From: La-Z-Boy Declares Quarterly Dividend to LabCorp to Offer BRCAssureSM Breast Cancer Mutation Tests


2013/8/21
MONROE, Mich.
Sign-up for La-Z-Boy Declares Quarterly Dividend investment picks
2013/8/28
http://media.marketwire.com/attachments/201308/TN-182283_L-Z-Boy_Award_Photo.jpg From left to right: President and CEO of RMHC, J.C. Gonzalez-Mendez; President International and Chief Marketing Officer of La-Z-Boy, Doug Collier; Board Chair of RMHC, Linda Dunham; and Chief Operating Officer of RMHC, Sheila Musolino.
Sign-up for La-Z-Boy Honored With RMHC Outstanding Stewardship Award investment picks
An eclectic mix perfectly proportioned for today's modern living spaces HIGH POINT, N.C. , Oct.
Sign-up for La-Z-Boy Introduces Urban Attitudes Collection at High Point Market investment picks
2013/8/20
MONROE, Mich.
Sign-up for La-Z-Boy Reports Fiscal 2014 First-Quarter Results investment picks
Increases dividend by 50% MONROE, Mich.
Sign-up for La-Z-Boy Reports Fiscal 2014 Second-Quarter Results investment picks
2014/2/18
MONROE, Mich.
Sign-up for La-Z-Boy Reports Fiscal 2014 Third-Quarter Results investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- La-Z-Boy Inc. shares rose in the extended session Tuesday after the furniture maker topped Wall Street estimates for the quarter and hiked its dividend.
Sign-up for La-Z-Boy shares get busy after hours investment picks
2013/11/19
SAN FRANCISCO (MarketWatch) -- La-Z-Boy Inc. (LZB) shares rose in the extended session Tuesday after the furniture company's quarterly results topped Wall Street estimates.
Sign-up for La-Z-Boy shares rise after results beat Street investment picks
2014/2/13
MONROE, Mich.
Sign-up for La-Z-Boy Signs Agreement to Sell Bauhaus, USA investment picks
2013/9/11
MONROE, Mich.
Sign-up for La-Z-Boy To Acquire Three La-Z-Boy Furniture Galleries® Stores In Las Vegas investment picks
2013/8/19
NEW YORK, Aug.
Sign-up for Labaton Sucharow LLP Files a Class Action Lawsuit on Behalf of Investors in LinnCo, LLC -- LNCO investment picks
2014/3/4
NEW YORK, March 4, 2014 (GLOBE NEWSWIRE) -- Labaton Sucharow LLP filed a class action lawsuit on March 4, 2014 in the U.S. District Court for the Eastern District of Virginia.
Sign-up for Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in NII Holdings, Inc. (NIHD) and NII Capital Corp. investment picks
2014/3/24
NEW YORK, March 24, 2014 (GLOBE NEWSWIRE) -- Labaton Sucharow LLP filed a class action lawsuit on March 24, 2014 in the U.S. District Court for the District of Utah.
Sign-up for Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Nu Skin Enterprises, Inc. (NUS) investment picks
2014/3/25
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced the appointment of Glenn A.
Sign-up for LabCorp Announces Appointment of Chief Financial Officer investment picks
2014/3/31
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that Drs.
Sign-up for LabCorp Announces Changes to Board of Directors investment picks
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that it plans to offer, subject to market and other conditions, senior notes that are expected to be issued in two tranches with maturities of 5 and 10 years (the “Notes”). The Notes will be senior unsecured obligations and will rank equally with LabCorp’s existing and future senior unsecured debt.
Sign-up for LabCorp Announces Proposed Sale of Senior Notes investment picks
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today the availability of a 4 th generation HIV antigen/antibody combination assay and a new diagnostic algorithm that improves screening for HIV infection.
Sign-up for LabCorp Announces the Availability of a 4th Generation HIV Assay to Allow the Earlier Detection of Acute HIV Infection investment picks
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today the immediate availability of an enhanced version of its HCV GenoSure ® NS3/4, a drug resistance test that screens for the Q80K polymorphism.
Sign-up for LabCorp Announces the Availability of Hepatitis C Virus Q80k Polymorphism Screening for the Newly Approved Drug OLYSIO™ (simeprevir) investment picks
2014/2/24
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today the availability of Thermo Scientific ImmunoCAP™ allergy testing products from Thermo Fisher Scientific, Inc. (NYSE: TMO). Allergies affect approximately 60 million individuals within the U.S. and this population is growing.
Sign-up for LabCorp Announces the Availability of Thermo Scientific ImmunoCAP™ Allergy Testing Products investment picks
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) applauds the recent recommendation of the National Kidney Foundation (NKF) that all persons age 60 or older receive urine screening for chronic kidney disease (CKD), defined as abnormalities of kidney structure or loss of kidney function over time.
Sign-up for LabCorp Applauds National Kidney Foundation’s Guidance about Testing for Chronic Kidney Disease; LabCorp’s CKD Program Provides Clinically Significant Data to Assist Diagnosis and Treatment investment picks
2014/1/6
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P.
Sign-up for LabCorp is Scheduled to Present at the 32nd Annual J.P. Morgan Healthcare Conference investment picks
2014/3/4
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P.
Sign-up for LabCorp is Scheduled to Present at the Barclays Capital 2014 Global Healthcare Conference investment picks
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P.
Sign-up for LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference investment picks
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE:LH) announced today that it has priced its offering of $700 million in senior notes.
Sign-up for LabCorp Prices $400 Million in 2.50% Senior Notes Due 2018 and $300 Million in 4.00% Senior Notes Due 2023 investment picks
Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today the nationwide availability of a suite of tests to identify patients with BRCA mutations who are at increased risk for breast, ovarian and other cancers.
Sign-up for LabCorp to Offer BRCAssureSM Breast Cancer Mutation Tests investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: La-Z-Boy Declares Quarterly Dividend to LabCorp to Offer BRCAssureSM Breast Cancer Mutation Tests
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity